⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21411550 | 1.00 | — | — | |
| SCHEMBL13318957 | 1.00 | — | — | |
| SCHEMBL158491 | 1.00 | — | — | |
| SCHEMBL30562964 | 1.00 | — | — | |
| SCHEMBL3696195 | 0.88 | SLC1A2 (0.62) | — | |
| SCHEMBL3696199 | 0.88 | SLC1A2 (0.62) | — | |
| SCHEMBL8530336 | 0.86 | SLC1A2 (0.60) | — | |
| SCHEMBL8126946 | 0.86 | SLC1A2 (0.60) | — | |
| SCHEMBL25662044 | 0.86 | SLC1A2 (0.60) | — | |
| SCHEMBL25660492 | 0.85 | SLC1A2 (0.58) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024238632-A2 | ASYMMETRIC CIRCULAR TANDEM REPEAT PROTEINS | Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute (US) | 2024-11-21 | — | — | WO | claimed |
| US-5688771-A | Lipophilic oligopeptides with immunomodulating activity | BIOCHEM PHARMA INC. (CA) | 1997-11-18 | — | — | US | claimed |
| CN-122075733-A | Preparation method and application of linker medicine and antibody-medicine conjugate thereof | — | 2026-05-26 | — | — | CN | disclosed |
| CN-122031713-A | Preparation method and application of linker medicine and antibody-medicine conjugate thereof | 乐普生物科技股份有限公司 | 2026-05-15 | — | — | CN | disclosed |
| EP-3966226-B1 | MASP INHIBITORY COMPOUNDS AND USES THEREOF | BAYER AG (DE) | 2025-12-24 | — | — | EP | disclosed |
| US-12503491-B2 | MASP inhibitory compounds and uses thereof | BAYER AKTIENGESELLSCHAFT (DE) | 2025-12-23 | — | — | US | disclosed |
| EP-4659764-A1 | LINKER DRUG, AND PREPARATION METHOD AND USE OF ANTIBODY-DRUG CONJUGATE THEREOF | Lepu Biopharma Co., Ltd. (CN) | 2025-12-10 | — | — | EP | disclosed |
| CN-120682140-A | Preparation method of (2S) -3-cyano-2-methyl-4-oxo piperidine-1-carboxylic acid tert-butyl ester | 内蒙古幸源新材料科技有限公司 | 2025-09-23 | — | — | CN | disclosed |
| CN-114585637-B | MASP-inhibitory compounds and uses thereof | 拜耳公司 | 2025-04-15 | — | — | CN | disclosed |
| WO-2024238632-A2 | ASYMMETRIC CIRCULAR TANDEM REPEAT PROTEINS | Seattle Children’s Hospital d/b/a Seattle Children’s Research Institute (US) | 2024-11-21 | — | — | WO | disclosed |
| US-20240287138-A1 | CYCLIC PEPTIDES FOR INHIBITING TNF RECEPTOR 1 ACTIVITY | MERCK SHARP & DOHME LLC | 2024-08-29 | — | — | US | disclosed |
| WO-2002038540-A9 | ACTIVITY-DEPENDENT CYSTEINE PROTEASE PROFILING REAGENT | UNIVERISTY OF CALIFORNIA (US) | 2004-03-04 | — | — | WO | disclosed |
| US-20020150961-A1 | Activity-dependent cysteine protease profiling reagent | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA OFFICE OF TECHNOLOGY MANAGEMENT | 2002-10-17 | — | — | US | disclosed |
| WO-2002038540-A2 | ACTIVITY-DEPENDENT CYSTEINE PROTEASE PROFILING REAGENT | THE REGENTS OF THE UNIVERISTY OF CALIFORNIA (US) | 2002-05-16 | — | — | WO | disclosed |
| US-6329502-B1 | VIRICIDES AGAINST HUMAN IMMUNODEFICIENCY VIRUS; TREATMENT OF AIDS (ACQUIRED IMMUNE DEFICIENCY SYNDROME) | JAPAN ENERGY CORPORATION (JP) | 2001-12-11 | — | — | US | disclosed |
| US-6313094-B1 | COMPOSITION FOR INHIBITING HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | JAPAN ENERGY CORPORATION (JP) | 2001-11-06 | — | — | US | disclosed |
| EP-0490667-B1 | HIV protease inhibitors | JAPAN ENERGY CORP (JP) | 1999-06-09 | — | — | EP | disclosed |
| US-5688771-A | Lipophilic oligopeptides with immunomodulating activity | BIOCHEM PHARMA INC. (CA) | 1997-11-18 | — | — | US | disclosed |
| EP-0635026-A1 | NOVEL LIPOPHILIC OLIGOPEPTIDES WITH IMMUNOMODULATING ACTIVITY | BIOCHEM PHARMA INC (CA) | 1995-01-25 | — | — | EP | disclosed |
| EP-0490667-A2 | HIV protease inhibitors | JAPAN ENERGY CORPORATION (JP) | 1992-06-17 | — | — | EP | disclosed |